COPD Asthma
Conditions
Keywords
Health coaching, COPD, Asthma, Access to specialty care
Brief summary
The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap syndrome (ACOS) for low-income and vulnerable patients seen at public health clinics. Three hundred sixty (360) patients from ten clinics will be enrolled in the study and randomized at the individual level to receive health coaching or usual care; 180 patients will receive usual care and 180 patients will receive the PuSHCon model.
Detailed description
While evidence-based care for chronic obstructive pulmonary disease (COPD) and asthma can substantially reduce disease burden and prevent emergency visits and hospitalizations, it is estimated that 55% of patients with COPD do not receive all recommended care and that less than 50% of patients with asthma are well controlled. The proposed study will evaluate the effectiveness of a novel model for pulmonary specialist-health coach consultations (PuSHCon) in its ability to increase access to specialty recommendations and the provision of evidence-based care for patients with chronic obstructive pulmonary disease (COPD) and/or asthma receiving care at federally qualified health centers (FQHCs). The specific aims of the study are to compare the use of evidence-based care and of patient reported outcomes 4 months after the consultation. In addition, the study will evaluate the cost per patient in each model to determine the model's effectiveness in increasing access and lowering cost. The first aim of comparing the use of evidence-based care will be measured as the proportion of guideline-based recommendations that are ultimately received by the patients. The secondary endpoint for this aim will be measured through the proportion of patients receiving guideline-concordant medications at 4 months after consultation compared to baseline. The second aim of the study regarding patient-reported outcomes will be measured primarily through the change in COPD and/or asthma related quality of life measures from baseline to 4 months post consultation. The secondary measure for this aim will look at changes in COPD and/or asthma specific symptom scores. The third aim of the study is to assess the impact of this model on access to care and cost of care. Access will be measured by tracking the number of patients who successfully complete a consultation per month. Costs will be determined by calculating time spent per patients, as well as by health care utilization.
Interventions
Pulmonary specialist consultation facilitated by a trained health coach, who will gather information from the patient and medical record prior to the consultation and will using health coaching skills to support implementation of recommended care.
The standard of care, which usually means management within primary care.
Sponsors
Study design
Masking description
Investigators and the Data Safety Monitoring Board will receive data summaries that mask identification of groups.
Intervention model description
Randomized controlled trial, with randomization at the individual level
Eligibility
Inclusion criteria
* English or Spanish speaking * At least 18 years of age * Diagnosed with asthma or COPD * Experiencing uncontrolled symptoms or exacerbations
Exclusion criteria
* Do not plan to attend primary care clinic for at least 3 months * Already engaged in pulmonary specialty care (defined as at least one visit in last 12 months) * Cognitive dysfunction that would prevent interaction with a health coach * Not having a phone at which the participant can be reached
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Receipt of Recommended Care | 16 weeks after enrollment | Numerator: Number of guideline-based recommendations implemented by the patient; Denominator: Number of minimal recommendations based on GOLD/GINA guidelines |
| Receipt of Recommended Medications | 16 weeks after enrollment | Numerator: Number of people receiving all minimal recommended medications based on GOLD/GINA guidelines; Denominator: Number of people enrolled in study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Medication Adherence | 16 weeks after enrollment | Number and percentage of patients taking all controller inhalers as prescribed for at least 5 of the last 7 days |
| Patient-reported Quality of Care | 16 weeks after enrollment | Mean score on Patient Assessment of Chronic Illness Care (PACIC) measure, with response options ranging from 1 (Almost never) to 5 (Almost Always). The scale is scored as an overall mean (1-5), with higher scores indicating a more frequent presence of high quality care. Four PACIC subscales (patient activation, delivery system practice design, goal setting/tailoring, problem solving/contextual), plus follow up/coordination are also represented by means of respective items. |
| Provider Acceptance of Recommended Care | 16 weeks after enrollment | Number of guideline-based recommendations where provider took action (e.g., prescribed or referred patient for care); Denominator: Number of minimal recommendations based on GOLD/GINA guidelines |
| Proportion of Patients Who Engaged in Chronic Lung Disease Education | 16 weeks after enrollment | Numerator: Number of people who engage with at least one existing resources such as group education classes or pulmonary care; Denominator: Number of people enrolled in the study |
| Disease Specific Symptoms Score (COPD & Asthma) | 16 weeks after enrollment | Score on St. George's Respiratory questionnaire (symptom subscale) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf) |
| Patient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score | 16 weeks after enrollment | Score on St. George's Respiratory questionnaire (overall) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf) |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| PuSHCon Model A health coach will contact patients with poorly controlled asthma or COPD. The health coach will gather information from the patient and medical record and review the case with a pulmonary specialist. The specialist will provide recommendations to the primary care clinician based on the case review; the specialist may request an in-person patient visit if needed. The health coach will follow up with the primary care clinician and will support implementation of recommendations that the the primary care clinician accepts, | 165 |
| Usual Care Patients with poorly controlled asthma or COPD will receive the standard of care, which usually means management within primary care. The study team will provide in-service sessions on COPD and asthma guidelines to primary care clinicians in both arms. As in standard practice, a primary care clinician may refer a patient for specialty consultation or diagnostic testing at any time. | 163 |
| Total | 328 |
Baseline characteristics
| Characteristic | Usual Care | PuSHCon Model | Total |
|---|---|---|---|
| Age, Continuous | 53.1 Years STANDARD_DEVIATION 14 | 51.9 Years STANDARD_DEVIATION 13.6 | 52.5 Years STANDARD_DEVIATION 13.8 |
| Breathing-related quality of life | 52.0 Scores on a scale STANDARD_DEVIATION 16.8 | 51.6 Scores on a scale STANDARD_DEVIATION 16.6 | 51.8 Scores on a scale STANDARD_DEVIATION 16.7 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 56 Participants | 59 Participants | 115 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 107 Participants | 106 Participants | 213 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 1 Participants | 1 Participants | 2 Participants |
| Race (NIH/OMB) Asian | 9 Participants | 7 Participants | 16 Participants |
| Race (NIH/OMB) Black or African American | 63 Participants | 60 Participants | 123 Participants |
| Race (NIH/OMB) More than one race | 6 Participants | 12 Participants | 18 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 2 Participants | 3 Participants | 5 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 63 Participants | 59 Participants | 122 Participants |
| Race (NIH/OMB) White | 19 Participants | 23 Participants | 42 Participants |
| Sex/Gender, Customized Female | 128 Participants | 118 Participants | 246 Participants |
| Sex/Gender, Customized Male | 34 Participants | 43 Participants | 77 Participants |
| Sex/Gender, Customized Other | 1 Participants | 4 Participants | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 165 | 0 / 163 |
| other Total, other adverse events | 0 / 165 | 0 / 163 |
| serious Total, serious adverse events | 0 / 165 | 0 / 163 |
Outcome results
Receipt of Recommended Care
Numerator: Number of guideline-based recommendations implemented by the patient; Denominator: Number of minimal recommendations based on GOLD/GINA guidelines
Time frame: 16 weeks after enrollment
| Arm | Measure | Value (MEAN) |
|---|---|---|
| PuSHCon Model | Receipt of Recommended Care | 38.2 Percentage of guidelines implemented |
| Usual Care | Receipt of Recommended Care | 23.7 Percentage of guidelines implemented |
Receipt of Recommended Medications
Numerator: Number of people receiving all minimal recommended medications based on GOLD/GINA guidelines; Denominator: Number of people enrolled in study
Time frame: 16 weeks after enrollment
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| PuSHCon Model | Receipt of Recommended Medications | 126 Participants |
| Usual Care | Receipt of Recommended Medications | 110 Participants |
Disease Specific Symptoms Score (COPD & Asthma)
Score on St. George's Respiratory questionnaire (symptom subscale) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf)
Time frame: 16 weeks after enrollment
Population: Includes individuals who completed a 16 week survey
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| PuSHCon Model | Disease Specific Symptoms Score (COPD & Asthma) | 40.8 Scores on a scale | Standard Deviation 21.1 |
| Usual Care | Disease Specific Symptoms Score (COPD & Asthma) | 49.7 Scores on a scale | Standard Deviation 21.2 |
Medication Adherence
Number and percentage of patients taking all controller inhalers as prescribed for at least 5 of the last 7 days
Time frame: 16 weeks after enrollment
Population: Includes individuals who completed the 16 week survey and reported taking a controller medication at the time
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| PuSHCon Model | Medication Adherence | 48 Participants |
| Usual Care | Medication Adherence | 42 Participants |
Patient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score
Score on St. George's Respiratory questionnaire (overall) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf)
Time frame: 16 weeks after enrollment
Population: Includes individuals who completed the 16 week survey
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| PuSHCon Model | Patient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score | 37.6 Scores on a scale | Standard Deviation 18.6 |
| Usual Care | Patient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score | 50.8 Scores on a scale | Standard Deviation 18.2 |
Patient-reported Quality of Care
Mean score on Patient Assessment of Chronic Illness Care (PACIC) measure, with response options ranging from 1 (Almost never) to 5 (Almost Always). The scale is scored as an overall mean (1-5), with higher scores indicating a more frequent presence of high quality care. Four PACIC subscales (patient activation, delivery system practice design, goal setting/tailoring, problem solving/contextual), plus follow up/coordination are also represented by means of respective items.
Time frame: 16 weeks after enrollment
Population: Includes individuals who completed the 16 week survey
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| PuSHCon Model | Patient-reported Quality of Care | 3.37 1-5 Likert Scale (5 best) | Standard Deviation 1.11 |
| Usual Care | Patient-reported Quality of Care | 3.12 1-5 Likert Scale (5 best) | Standard Deviation 1.12 |
Proportion of Patients Who Engaged in Chronic Lung Disease Education
Numerator: Number of people who engage with at least one existing resources such as group education classes or pulmonary care; Denominator: Number of people enrolled in the study
Time frame: 16 weeks after enrollment
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| PuSHCon Model | Proportion of Patients Who Engaged in Chronic Lung Disease Education | 126 Participants |
| Usual Care | Proportion of Patients Who Engaged in Chronic Lung Disease Education | 91 Participants |
Provider Acceptance of Recommended Care
Number of guideline-based recommendations where provider took action (e.g., prescribed or referred patient for care); Denominator: Number of minimal recommendations based on GOLD/GINA guidelines
Time frame: 16 weeks after enrollment
Population: Number of recommendations accepted out of those provided
| Arm | Measure | Value (COUNT_OF_UNITS) |
|---|---|---|
| PuSHCon Model | Provider Acceptance of Recommended Care | 2425 Recommendations |